美国 · 平台与数据 · Yahoo Finance
Madrigal Pharmaceuticals (MDGL) Stock May Be Below Fair Value Despite First Profit
Madrigal Pharmaceuticals has gone from a relatively small specialist to a business with more than US$1b in annualised sales from its liver drug Rezdiffra, yet the share price has…
在 Yahoo Finance 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)
